Mastodon

Aevit (Capsules) Instructions for Use

ATC Code

A11JA (Vitamins in combination)

Active Substances

Retinol (Rec.INN registered by WHO)

Tocopherol (Ph.Eur. European Pharmacopoeia)

Clinical-Pharmacological Group

Vitamin complex

Pharmacotherapeutic Group

Vitamins; other combined vitamin preparations; combinations of vitamins

Pharmacological Action

A combined medicinal product, the action of which is determined by the properties of the fat-soluble vitamins A and E that are part of it.

Retinol (vitamin A) is a necessary component for the normal function of the retina of the eye: binding with opsin (the red pigment of the retina), it forms the visual purple rhodopsin, which is necessary for visual adaptation in the dark. Vitamin A is necessary for bone growth, normal reproductive function, embryonic development, and for the regulation of division and differentiation of the epithelium (enhances the reproduction of skin epithelial cells, rejuvenates the cell population, and inhibits keratinization processes). Vitamin A participates as a co-factor in various biochemical processes.

The function of α-tocopherol (vitamin E): as an antioxidant, it inhibits the development of free radical reactions, prevents the formation of peroxides that damage cellular and subcellular membranes, which is important for the development of the body, the normal function of the nervous and muscular systems. Together with selenium, it inhibits the oxidation of unsaturated fatty acids (a component of the microsomal electron transfer system), and prevents hemolysis of erythrocytes. It is a co-factor of some enzyme systems. It restores capillary circulation, normalizes capillary and tissue permeability, and increases tissue resistance to hypoxia.

Pharmacokinetics

Tocopherol when taken orally is slowly absorbed, approximately 50% of the taken dose of the drug, Cmax after 4 hours. The presence of bile acids is necessary for absorption. It is deposited in the adrenal glands, pituitary gland, testes, adipose and muscle tissue, erythrocytes, and liver. It is metabolized and excreted from the body (unchanged and in the form of metabolites) with bile (over 90%) and urine (about 6%).

Retinol when taken orally, retinol is absorbed almost completely, even with excessive administration, no more than 10% of the administered amount is excreted with feces. In the process of metabolism, retinyl palmitate, retinol, retinal, and retinoic acid are formed. It is distributed unevenly in the body: the largest amount is in the liver and retina, less is in the kidneys, heart, fat depots, lungs, lactating mammary gland, in the adrenal glands and other endocrine glands. Retinol, retinal, retinoic acid are excreted by hepatocytes as part of bile, retinoylglucuronide is excreted in the urine.

The elimination of fat-soluble vitamins (tocopherol and retinol) is slow, so repeated doses lead to accumulation.

Indications

Hypo- and avitaminosis A and E, as well as conditions of increased body demand for vitamins A and E and/or reduced intake into the body: gastrectomy, diarrhea, steatorrhea, celiac disease, Crohn’s disease, malabsorption syndrome, chronic cholestasis, liver cirrhosis, biliary atresia, obstructive jaundice, cystic fibrosis of the pancreas, tropical sprue, infectious diseases (including chronic and “cold” ones), hemeralopia, xerophthalmia, keratomalacia, inadequate and unbalanced nutrition (including parenteral nutrition), rapid weight loss, nicotine dependence, drug addiction, state of prolonged stress, taking cholestyramine, colestipol, mineral oils, neomycin, iron-containing products, when prescribing a diet with an increased content of polyunsaturated fatty acids, hyperthyroidism.

Peripheral neuropathy, necrotizing myopathy, abetalipoproteinemia.

ICD codes

ICD-10 code Indication
A09 Other and unspecified gastroenteritis and colitis of infectious origin
E05 Thyrotoxicosis [hyperthyroidism]
E50 Vitamin A deficiency
E56.0 Vitamin E deficiency
E63.1 Disparate intake of food elements
E78.6 Lipoprotein deficiency
E84.1 Cystic fibrosis with intestinal manifestations
F11 Mental and behavioral disorders due to opioid use
F17 Mental and behavioural disorders due to use of tobacco
G62.9 Polyneuropathy, unspecified
G72 Other myopathies
H04.1 Other disorders of lacrimal gland (dry eye syndrome)
H18.4 Corneal degeneration
H53.1 Subjective visual disturbances
J06.9 Acute upper respiratory infection, unspecified
K50 Crohn's disease [regional enteritis]
K59.1 Functional diarrhea
K74 Fibrosis and cirrhosis of liver
K83.9 Disease of biliary tract, unspecified
K90.0 Coeliac disease
K90.1 Tropical sprue
K90.3 Pancreatic steatorrhea
K90.4 Malabsorption due to intolerance, not elsewhere classified
K91.1 Postgastric surgery syndromes
R17 Hyperbilirubinemia, with or without jaundice, not elsewhere classified
Y57.8 Other drugs and medicaments
Z73.3 Stress, not elsewhere classified (physical and mental strain)
ICD-11 code Indication
1A40.Z Infectious gastroenteritis or colitis, unspecified
5A02.Z Thyrotoxicosis, unspecified
5B55.Z Vitamin A deficiency, unspecified
5B58 Vitamin E deficiency
5B7Z Malnutrition, unspecified
5C81.Z Hypolipoproteinemia, unspecified
6C43.Z Disorders due to opioid use, unspecified
6C4A.Z Disorders due to nicotine use, unspecified
8C4Z Disorders of nerve roots, plexuses or peripheral nerves, unspecified
8C8Z Secondary myopathies, unspecified
8D40.1 Neuropathy due to nutritional deficiency
9A1Z Diseases of the lacrimal system, unspecified
9A78.4 Corneal degeneration
9D51 Transient vision loss
9D5Z Subjective visual disturbances, unspecified
CA07.0 Acute upper respiratory tract infection of unspecified site
CA25.1 Atypical cystic fibrosis
CA25.Z Cystic fibrosis, unspecified
DA95 Coeliac disease
DA96.01 Tropical sprue
DA96.02 Malabsorption or intolerance of specific nutrients
DA96.1 Protein-losing enteropathy
DA96.Z Malabsorption syndrome or protein-losing enteropathy, unspecified
DB93 Fibrosis or cirrhosis of liver
DC10.Z Acquired structural (organic) changes of gallbladder or bile ducts, unspecified
DC14.Z Diseases of the biliary tract, unspecified
DC1Z Diseases of gallbladder and biliary tract, unspecified
DC35.2 Pancreatic steatorrhea
DD70.Z Crohn's disease, unspecified location
DD91.2 Functional diarrhea
DD93.Y Other specified functional gastrointestinal disorders in infants, toddlers and school-age children
DD9Z Functional gastrointestinal disorders, unspecified
DE11 Dumping syndrome
ME10.1 Unspecified jaundice
PL00 Drugs, medicaments or biological substances causing injury or harm in therapeutic use
QE01 Stress, not elsewhere classified
CA25.0 Classic cystic fibrosis
DB98.74 Secondary portal hypertension

Dosage Regimen

The method of application and dosage regimen for a specific drug depend on its form of release and other factors. The optimal dosage regimen is determined by the doctor. It is necessary to strictly adhere to the compliance of the dosage form of a specific drug with the indications for use and dosage regimen.

Take orally. Swallow the capsule whole with a sufficient amount of water.

Adhere strictly to the individual dosing regimen established by a physician. The regimen is determined by the specific indication, severity of the condition, and patient factors.

For the treatment of avitaminosis A and E, the typical adult dose is one capsule (100,000 IU vitamin A, 100 mg vitamin E) per day.

The duration of therapy is determined by the physician. Do not exceed the prescribed daily dose or treatment duration to avoid the risk of hypervitaminosis.

For conditions of increased demand or malabsorption (e.g., post-gastrectomy, chronic cholestasis, cystic fibrosis, Crohn’s disease), the dosage and duration are set individually based on clinical need.

In cases of peripheral neuropathy or necrotizing myopathy, the therapeutic course may be prolonged; follow medical supervision.

This product contains high, therapeutic doses of vitamins and is not intended for prophylactic use or for self-medication without a diagnosis.

Contraindicated in children and adolescents under 18 years of age, during pregnancy, and breastfeeding.

Use with caution in elderly patients and in those with severe liver or renal impairment, thyrotoxicosis, or a history of cholelithiasis.

Adverse Reactions

Systemic reactions allergic reactions.

From the digestive system pain in the epigastric region, dyspeptic disorders (nausea, vomiting, diarrhea); with long-term use in large doses, exacerbation of cholelithiasis and chronic pancreatitis is possible.

Local reactions (with intramuscular injection) – pain, infiltrate, calcification of soft tissues.

Contraindications

Hypersensitivity, hypervitaminosis A and E, childhood (under 18 years), pregnancy, lactation period.

With caution

Thyrotoxicosis, cholecystitis, conditions accompanied by increased vascular permeability (CHF, chronic glomerulonephritis, etc.), liver cirrhosis, viral hepatitis, renal failure, alcoholism, old age, hypoprothrombinemia (against the background of vitamin K deficiency – may be enhanced at a vitamin E dose of more than 400 IU).

Use in Pregnancy and Lactation

Contraindicated during pregnancy and during lactation (breastfeeding).

Use in Hepatic Impairment

With caution liver cirrhosis, viral hepatitis, renal failure.

Use in Renal Impairment

With caution renal failure, conditions accompanied by increased vascular permeability (CHF, chronic glomerulonephritis, etc.).

Pediatric Use

Contraindicated under the age of 18 years.

Geriatric Use

With caution old age.

Special Precautions

To avoid the development of hypervitaminosis A and E, the recommended doses should not be exceeded.

When using the drug, one should take into account the high content of vitamin A (100 thousand IU) in it, as well as the fact that it is a therapeutic, not a prophylactic drug.

A diet with an increased content of Se and sulfur-containing amino acids reduces the need for vitamin E.

Drug Interactions

Retinol weakens the effect of calcium preparations, increases the risk of hypercalcemia.

Cholestyramine, colestipol, mineral oils, neomycin reduce the absorption of vitamins A and E (an increase in their dose may be required).

Oral contraceptives increase the concentration of retinol in plasma.

Isotretinoin increases the risk of retinol intoxication.

Simultaneous use of tetracycline and retinol in high doses (50 thousand IU and above) increases the risk of intracranial hypertension.

Tocopherol (vitamin E) enhances the effect of corticosteroids, NSAIDs, antioxidants, increases the effectiveness and reduces the toxicity of vitamins A, D, cardiac glycosides. Prescription of vitamin E in high doses can cause deficiency of vitamin A in the body.

Tocopherol (vitamin E) increases the effectiveness of antiepileptic drugs in patients with epilepsy (who have an increased content of lipid peroxidation products in the blood).

Simultaneous use of vitamin E in a dose of more than 400 IU/day with anticoagulants (coumarin and indandione derivatives) increases the risk of hypoprothrombinemia and bleeding.

Use of iron preparations in high doses enhances oxidative processes in the body, which increases the need for vitamin E.

Storage Conditions

Store at 2°C (36°F) to 25°C (77°F). Keep in original packaging, protected from light. Keep out of reach of children.

Dispensing Status

Over-the-Counter

Important Safety Information

This information is for educational purposes only and does not replace professional medical advice. Always consult your doctor before use. Dosage and side effects may vary. Use only as prescribed.

Medical Disclaimer

Brand (or Active Substance), Marketing Authorisation Holder, Dosage Form

Marketing Authorization Holder

Altayvitamins, JSC (Russia)

Dosage Form

Bottle OTC Icon Aevit Capsules 55 mg+100 mg: 10, 20, 30, 40, or 50 pcs.

Dosage Form, Packaging, and Composition

Capsules 1 caps.
Retinyl palmitate (vit. A) 55 mg (100,000 IU)
α-Tocopherol acetate (vit. E) 100 mg

10 pcs. – blister packs (1) – cardboard packs.
10 pcs. – blister packs (2) – cardboard packs.
10 pcs. – blister packs (3) – cardboard packs.
10 pcs. – blister packs (4) – cardboard packs.
10 pcs. – blister packs (5) – cardboard packs.

Marketing Authorization Holder

Bryntsalov-A, JSC (Russia)

Dosage Form

Bottle OTC Icon Aevit Capsules: 10 and 25 pcs.

Dosage Form, Packaging, and Composition

Capsules 1 caps.
α-Tocopherol acetate 100 mg
55% oily solution of retinyl palmitate 0.1 ml

25 pcs. – dark glass jars (1) – cardboard packs.
25 pcs. – polymer jars (1) – cardboard packs.
10 pcs. – contour blister packs.
25 pcs. – polyethylene bottles.

Marketing Authorization Holder

Intermed LLC (Russia)

Manufactured By

Biopharmkombinat, LLC (Russia)

Dosage Form

Bottle OTC Icon Aevit Capsules 100 mg+58 mg: 20, 30, 40, 500, 840, 1000, 1080, 1260, 1620, 1680, 2000, or 2160 pcs.

Dosage Form, Packaging, and Composition

Capsules soft gelatin, spherical in shape, from yellow to light brown in color, filled with an oily liquid from light yellow to dark yellow in color, without a rancid odor.

1 caps.
Tocopherol acetate (vit. E) 100 mg
Retinol (vit. A)* 58 mg* (100,000 IU)

* 1 g of Retinol substance (vitamin A palmitate, substance, stabilized with BHA/BHT – oily solution) contains: retinyl palmitate – 1.7 million IU, butylhydroxyanisole (BHA) – 9 mg, butylhydroxytoluene (BHT) – 9 mg.

PRING] sunflower oil – up to 200 mg.

Shell composition (in terms of absolute dry substance) gelatin – 52.75 mg, glycerol – 16.8 mg, methylparahydroxybenzoate – 0.45 mg.

10 pcs. – contour blister packs (2) – cardboard packs.
10 pcs. – contour blister packs (3) – cardboard packs.
10 pcs. – contour blister packs (4) – cardboard packs.
20 pcs. – polyethylene jars (1) – cardboard packs.
30 pcs. – polyethylene jars (1) – cardboard packs.
40 pcs. – polyethylene jars (1) – cardboard packs.
10 pcs. – contour blister packs (50) – cardboard boxes (for hospitals).
10 pcs. – contour blister packs (100) – cardboard boxes (for hospitals).
10 pcs. – contour blister packs (200) – cardboard boxes (for hospitals).
20 pcs. – polyethylene jars (42) – cardboard boxes (for hospitals).
20 pcs. – polyethylene jars (54) – cardboard boxes (for hospitals).
30 pcs. – polyethylene jars (42) – cardboard boxes (for hospitals).
30 pcs. – polyethylene jars (54) – cardboard boxes (for hospitals).
40 pcs. – polyethylene jars (42) – cardboard boxes (for hospitals).
40 pcs. – polyethylene jars (54) – cardboard boxes (for hospitals).

Marketing Authorization Holder

Lumi, LLC (Russia)

Dosage Form

Bottle OTC Icon Aevit Capsules 100 mg+35 mg: 30 pcs.

Dosage Form, Packaging, and Composition

Capsules 1 caps.
α-Tocopherol acetate (vit. E) 100 mg
Retinyl palmitate (vit. A) 35 mg (100000 IU)

10 pcs. – contour blister packs (3) – cardboard packs.

Marketing Authorization Holder

Marbiopharm, JSC (Russia)

Dosage Form

Bottle OTC Icon Aevit Capsules: 10, 20, 30, 50, or 100 pcs.

Dosage Form, Packaging, and Composition

Capsules soft gelatin, spherical in shape, from dark yellow to light brown in color, filled with an oily liquid from light yellow to dark yellow in color, without a rancid odor.

1 caps.
Retinyl palmitate 0.055036 g (100000 IU)
α-Tocopherol acetate 0.1 g (100 IU)

Excipients: sunflower oil – up to 0.2 g.

Capsule shell composition: gelatin – 0.036913 g, glycerol – 0.011865 g, methylparaben – 0.000264 g, instant natural coffee – 0.000958 g.

10 pcs. – contour cell packs (1) – cardboard packs.
10 pcs. – contour cell packs (2) – cardboard packs.
10 pcs. – contour cell packs (3) – cardboard packs.
10 pcs. – contour cell packs (5) – cardboard packs.
10 pcs. – contour cell packs (10) – cardboard packs.
150 pcs. – contour cell packs (1) – cardboard packs.

Marketing Authorization Holder

Meligen FP, CJS (Russia)

Dosage Form

Bottle OTC Icon Aevit Capsules 100 mg+55 mg: 10, 20, 30, 40, 100, or 500 pcs.

Dosage Form, Packaging, and Composition

Capsules soft gelatin, spherical in shape, from yellow to light brown in color; the capsule contents are an oily liquid from light yellow to dark yellow in color, without a rancid odor.

1 caps.
α-Tocopherol acetate 100 mg
Retinyl palmitate 35 mg (100 thousand IU)

Excipients: sunflower oil – 45 mg, gelatin – 44.73 mg, glycerol – 14.67 mg, methylparaben – 0.29 mg, sugar color – 0.31 mg.

10 pcs. – contour cell packs (1) – cardboard packs.
10 pcs. – contour cell packs (2) – cardboard packs.
10 pcs. – contour cell packs (3) – cardboard packs.
10 pcs. – contour cell packs (4) – cardboard packs.
10 pcs. – contour cell packs (10) – cardboard packs.
10 pcs. – contour cell packs (50) – cardboard packs.

Marketing Authorization Holder

Minskintercaps Up (Republic Of Belarus)

Dosage Form

Bottle OTC Icon Aevit Capsules 100 mg+100 thousand IU: 10 or 20 pcs.

Dosage Form, Packaging, and Composition

Capsules 1 caps.
α-Tocopherol acetate 100 mg
Retinyl acetate (or retinyl palmitate) 100 000 IU

10 pcs. – blisters (1) – cardboard packs.
10 pcs. – blisters (2) – cardboard packs.

Marketing Authorization Holder

Tula Pharmaceutical Factory, LLC (Russia)

Dosage Form

Bottle OTC Icon Aevit Capsules 100 mg+58 mg: 20, 30, 40, 500, 840, 1000, 1080, 1260, 1620, 1680, 2000, or 2160 pcs.

Dosage Form, Packaging, and Composition

Capsules soft gelatin, spherical in shape, from yellow to light brown in color, filled with an oily liquid from light yellow to dark yellow in color, without a rancid odor.

1 caps.
α-Tocopherol acetate 100 mg
Retinyl acetate (vit. A) 58 mg (100 thousand IU)

* 1 g of retinyl palmitate (vit. A) substance, stabilized with BHA/BHT contains: retinyl palmitate – 1.7 million IU, butylated hydroxyanisole (BHA) – 9 mg, butylated hydroxytoluene (BHT) – 9 mg.

PRING] sunflower oil – up to 200 mg.

Shell composition (calculated on absolute dry substance) gelatin – 52.75 mg, glycerol – 16.8 mg, methylparaben – 0.45 mg.

10 pcs. – contour cell packs (2) – cardboard packs.
10 pcs. – contour cell packs (3) – cardboard packs.
10 pcs. – contour cell packs (4) – cardboard packs.
20 pcs. – polymer jars (1) – cardboard packs.
30 pcs. – polymer jars (1) – cardboard packs.
40 pcs. – polymer jars (1) – cardboard packs.
10 pcs. – contour cell packs (50) – cardboard boxes (for hospitals).
10 pcs. – contour cell packs (100) – cardboard boxes (for hospitals).
10 pcs. – contour cell packs (200) – cardboard boxes (for hospitals).
20 pcs. – polymer jars (42) – cardboard boxes (for hospitals).
20 pcs. – polymer jars (54) – cardboard boxes (for hospitals).
30 pcs. – polymer jars (42) – cardboard boxes (for hospitals).
30 pcs. – polymer jars (54) – cardboard boxes (for hospitals).
40 pcs. – polymer jars (42) – cardboard boxes (for hospitals).
40 pcs. – polymer jars (54) – cardboard boxes (for hospitals).

Marketing Authorization Holder

Pharmalena, CJSC (Russia)

Dosage Form

Bottle OTC Icon Aevit Capsules: 10 and 25 pcs.

Dosage Form, Packaging, and Composition

Capsules 1 caps.
α-Tocopherol acetate 100 mg
55% oily solution of retinyl palmitate 0.1 ml

25 pcs. – dark glass jars (1) – cardboard packs.
25 pcs. – polymer jars (1) – cardboard packs.
10 pcs. – contour cell packs.
25 pcs. – polyethylene bottles.

TABLE OF CONTENTS